nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2A—Doxorubicin—kidney cancer	0.222	1	CbGbCtD
Dexrazoxane—TOP2B—nephron tubule—kidney cancer	0.0059	0.19	CbGeAlD
Dexrazoxane—TOP2B—renal system—kidney cancer	0.00536	0.172	CbGeAlD
Dexrazoxane—TOP2B—kidney—kidney cancer	0.00519	0.167	CbGeAlD
Dexrazoxane—TOP2B—cortex of kidney—kidney cancer	0.00505	0.162	CbGeAlD
Dexrazoxane—TOP2B—gonad—kidney cancer	0.00481	0.155	CbGeAlD
Dexrazoxane—TOP2B—cardiac atrium—kidney cancer	0.0048	0.154	CbGeAlD
Dexrazoxane—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.00343	0.227	CbGdCrCtD
Dexrazoxane—TOP2A—Vindesine—Vincristine—kidney cancer	0.00174	0.115	CbGdCrCtD
Dexrazoxane—TOP2A—Vindesine—Vinblastine—kidney cancer	0.00174	0.115	CbGdCrCtD
Dexrazoxane—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.00164	0.109	CbGdCrCtD
Dexrazoxane—TOP2A—Vinorelbine—Vinblastine—kidney cancer	0.0011	0.0728	CbGdCrCtD
Dexrazoxane—TOP2A—Vinorelbine—Vincristine—kidney cancer	0.0011	0.0728	CbGdCrCtD
Dexrazoxane—TOP2A—Vincristine—Vinblastine—kidney cancer	0.00094	0.0623	CbGdCrCtD
Dexrazoxane—TOP2A—Vinblastine—Vincristine—kidney cancer	0.000756	0.0501	CbGdCrCtD
Dexrazoxane—TOP2A—Cytarabine—Gemcitabine—kidney cancer	0.000618	0.0409	CbGdCrCtD
Dexrazoxane—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	0.00053	0.0351	CbGdCrCtD
Dexrazoxane—TOP2A—Idarubicin—Doxorubicin—kidney cancer	0.00053	0.0351	CbGdCrCtD
Dexrazoxane—TOP2A—Epirubicin—Doxorubicin—kidney cancer	0.00053	0.0351	CbGdCrCtD
Dexrazoxane—TOP2A—Azacitidine—Gemcitabine—kidney cancer	0.000443	0.0293	CbGdCrCtD
Dexrazoxane—Myalgia—Gemcitabine—kidney cancer	0.000435	0.000594	CcSEcCtD
Dexrazoxane—Alopecia—Paclitaxel—kidney cancer	0.000434	0.000593	CcSEcCtD
Dexrazoxane—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000432	0.00059	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000432	0.00059	CcSEcCtD
Dexrazoxane—Nervous system disorder—Vincristine—kidney cancer	0.000431	0.000589	CcSEcCtD
Dexrazoxane—Asthenia—Erlotinib—kidney cancer	0.000431	0.000588	CcSEcCtD
Dexrazoxane—Mental disorder—Paclitaxel—kidney cancer	0.00043	0.000588	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Vincristine—kidney cancer	0.00043	0.000588	CcSEcCtD
Dexrazoxane—Discomfort—Gemcitabine—kidney cancer	0.00043	0.000587	CcSEcCtD
Dexrazoxane—Urticaria—Sorafenib—kidney cancer	0.000429	0.000586	CcSEcCtD
Dexrazoxane—Malnutrition—Paclitaxel—kidney cancer	0.000428	0.000584	CcSEcCtD
Dexrazoxane—Erythema—Paclitaxel—kidney cancer	0.000428	0.000584	CcSEcCtD
Dexrazoxane—Decreased appetite—Dactinomycin—kidney cancer	0.000427	0.000584	CcSEcCtD
Dexrazoxane—Diarrhoea—Vinblastine—kidney cancer	0.000427	0.000584	CcSEcCtD
Dexrazoxane—Abdominal pain—Sorafenib—kidney cancer	0.000427	0.000583	CcSEcCtD
Dexrazoxane—Body temperature increased—Sorafenib—kidney cancer	0.000427	0.000583	CcSEcCtD
Dexrazoxane—Diarrhoea—Everolimus—kidney cancer	0.000425	0.000581	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Sunitinib—kidney cancer	0.000425	0.00058	CcSEcCtD
Dexrazoxane—Pruritus—Erlotinib—kidney cancer	0.000425	0.00058	CcSEcCtD
Dexrazoxane—Fatigue—Dactinomycin—kidney cancer	0.000424	0.000579	CcSEcCtD
Dexrazoxane—Pain—Dactinomycin—kidney cancer	0.000421	0.000575	CcSEcCtD
Dexrazoxane—Agranulocytosis—Capecitabine—kidney cancer	0.000419	0.000573	CcSEcCtD
Dexrazoxane—Anorexia—Vincristine—kidney cancer	0.000419	0.000572	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000414	0.000566	CcSEcCtD
Dexrazoxane—Infection—Gemcitabine—kidney cancer	0.000414	0.000566	CcSEcCtD
Dexrazoxane—Dizziness—Vinblastine—kidney cancer	0.000413	0.000564	CcSEcCtD
Dexrazoxane—Dizziness—Everolimus—kidney cancer	0.000411	0.000562	CcSEcCtD
Dexrazoxane—Body temperature increased—Sunitinib—kidney cancer	0.000411	0.000561	CcSEcCtD
Dexrazoxane—Abdominal pain—Sunitinib—kidney cancer	0.000411	0.000561	CcSEcCtD
Dexrazoxane—Diarrhoea—Erlotinib—kidney cancer	0.000411	0.000561	CcSEcCtD
Dexrazoxane—Nervous system disorder—Gemcitabine—kidney cancer	0.000409	0.000558	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Gemcitabine—kidney cancer	0.000408	0.000558	CcSEcCtD
Dexrazoxane—Feeling abnormal—Dactinomycin—kidney cancer	0.000405	0.000554	CcSEcCtD
Dexrazoxane—Haemoglobin—Capecitabine—kidney cancer	0.000405	0.000554	CcSEcCtD
Dexrazoxane—Skin disorder—Gemcitabine—kidney cancer	0.000405	0.000553	CcSEcCtD
Dexrazoxane—Haemorrhage—Capecitabine—kidney cancer	0.000403	0.000551	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000402	0.000549	CcSEcCtD
Dexrazoxane—Tremor—Paclitaxel—kidney cancer	0.000401	0.000547	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Vincristine—kidney cancer	0.0004	0.000547	CcSEcCtD
Dexrazoxane—Insomnia—Vincristine—kidney cancer	0.000397	0.000543	CcSEcCtD
Dexrazoxane—Anorexia—Gemcitabine—kidney cancer	0.000397	0.000543	CcSEcCtD
Dexrazoxane—Oedema peripheral—Capecitabine—kidney cancer	0.000397	0.000543	CcSEcCtD
Dexrazoxane—Vomiting—Vinblastine—kidney cancer	0.000397	0.000542	CcSEcCtD
Dexrazoxane—Dizziness—Erlotinib—kidney cancer	0.000397	0.000542	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Paclitaxel—kidney cancer	0.000397	0.000542	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Capecitabine—kidney cancer	0.000396	0.000541	CcSEcCtD
Dexrazoxane—Vomiting—Everolimus—kidney cancer	0.000395	0.00054	CcSEcCtD
Dexrazoxane—Anaemia—Paclitaxel—kidney cancer	0.000395	0.00054	CcSEcCtD
Dexrazoxane—Headache—Vinblastine—kidney cancer	0.000391	0.000534	CcSEcCtD
Dexrazoxane—Headache—Everolimus—kidney cancer	0.00039	0.000532	CcSEcCtD
Dexrazoxane—Body temperature increased—Dactinomycin—kidney cancer	0.000389	0.000531	CcSEcCtD
Dexrazoxane—Abdominal pain—Dactinomycin—kidney cancer	0.000389	0.000531	CcSEcCtD
Dexrazoxane—Asthenia—Sorafenib—kidney cancer	0.000387	0.000529	CcSEcCtD
Dexrazoxane—Malaise—Paclitaxel—kidney cancer	0.000386	0.000527	CcSEcCtD
Dexrazoxane—Syncope—Paclitaxel—kidney cancer	0.000383	0.000524	CcSEcCtD
Dexrazoxane—Leukopenia—Paclitaxel—kidney cancer	0.000383	0.000523	CcSEcCtD
Dexrazoxane—Decreased appetite—Vincristine—kidney cancer	0.000382	0.000522	CcSEcCtD
Dexrazoxane—Pruritus—Sorafenib—kidney cancer	0.000382	0.000522	CcSEcCtD
Dexrazoxane—Vomiting—Erlotinib—kidney cancer	0.000382	0.000521	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00038	0.000519	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Vincristine—kidney cancer	0.000379	0.000518	CcSEcCtD
Dexrazoxane—Fatigue—Vincristine—kidney cancer	0.000379	0.000518	CcSEcCtD
Dexrazoxane—Hyponatraemia—Doxorubicin—kidney cancer	0.000377	0.000515	CcSEcCtD
Dexrazoxane—Insomnia—Gemcitabine—kidney cancer	0.000377	0.000515	CcSEcCtD
Dexrazoxane—Headache—Erlotinib—kidney cancer	0.000376	0.000514	CcSEcCtD
Dexrazoxane—Loss of consciousness—Paclitaxel—kidney cancer	0.000376	0.000513	CcSEcCtD
Dexrazoxane—Constipation—Vincristine—kidney cancer	0.000376	0.000513	CcSEcCtD
Dexrazoxane—Pain—Vincristine—kidney cancer	0.000376	0.000513	CcSEcCtD
Dexrazoxane—Cardiac disorder—Capecitabine—kidney cancer	0.000374	0.000511	CcSEcCtD
Dexrazoxane—Cough—Paclitaxel—kidney cancer	0.000373	0.00051	CcSEcCtD
Dexrazoxane—Asthenia—Sunitinib—kidney cancer	0.000373	0.000509	CcSEcCtD
Dexrazoxane—Dyspnoea—Gemcitabine—kidney cancer	0.000372	0.000508	CcSEcCtD
Dexrazoxane—Nausea—Vinblastine—kidney cancer	0.000371	0.000507	CcSEcCtD
Dexrazoxane—Somnolence—Gemcitabine—kidney cancer	0.000371	0.000506	CcSEcCtD
Dexrazoxane—Nausea—Everolimus—kidney cancer	0.000369	0.000505	CcSEcCtD
Dexrazoxane—Diarrhoea—Sorafenib—kidney cancer	0.000369	0.000505	CcSEcCtD
Dexrazoxane—Pruritus—Sunitinib—kidney cancer	0.000368	0.000502	CcSEcCtD
Dexrazoxane—Angiopathy—Capecitabine—kidney cancer	0.000366	0.0005	CcSEcCtD
Dexrazoxane—Myalgia—Paclitaxel—kidney cancer	0.000364	0.000497	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Capecitabine—kidney cancer	0.000363	0.000496	CcSEcCtD
Dexrazoxane—Decreased appetite—Gemcitabine—kidney cancer	0.000362	0.000495	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000362	0.000494	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00036	0.000492	CcSEcCtD
Dexrazoxane—Discomfort—Paclitaxel—kidney cancer	0.00036	0.000491	CcSEcCtD
Dexrazoxane—Fatigue—Gemcitabine—kidney cancer	0.000359	0.000491	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Vincristine—kidney cancer	0.000359	0.000491	CcSEcCtD
Dexrazoxane—Dizziness—Sorafenib—kidney cancer	0.000357	0.000488	CcSEcCtD
Dexrazoxane—Constipation—Gemcitabine—kidney cancer	0.000356	0.000487	CcSEcCtD
Dexrazoxane—Pain—Gemcitabine—kidney cancer	0.000356	0.000487	CcSEcCtD
Dexrazoxane—Nausea—Erlotinib—kidney cancer	0.000356	0.000487	CcSEcCtD
Dexrazoxane—Alopecia—Capecitabine—kidney cancer	0.000356	0.000487	CcSEcCtD
Dexrazoxane—Dry mouth—Paclitaxel—kidney cancer	0.000356	0.000486	CcSEcCtD
Dexrazoxane—Diarrhoea—Sunitinib—kidney cancer	0.000355	0.000486	CcSEcCtD
Dexrazoxane—Mental disorder—Capecitabine—kidney cancer	0.000353	0.000483	CcSEcCtD
Dexrazoxane—Asthenia—Dactinomycin—kidney cancer	0.000353	0.000482	CcSEcCtD
Dexrazoxane—Blood creatinine increased—Doxorubicin—kidney cancer	0.000352	0.000481	CcSEcCtD
Dexrazoxane—Erythema—Capecitabine—kidney cancer	0.000351	0.000479	CcSEcCtD
Dexrazoxane—Malnutrition—Capecitabine—kidney cancer	0.000351	0.000479	CcSEcCtD
Dexrazoxane—Abdominal pain—Vincristine—kidney cancer	0.000347	0.000475	CcSEcCtD
Dexrazoxane—Body temperature increased—Vincristine—kidney cancer	0.000347	0.000475	CcSEcCtD
Dexrazoxane—Infection—Paclitaxel—kidney cancer	0.000347	0.000474	CcSEcCtD
Dexrazoxane—Dizziness—Sunitinib—kidney cancer	0.000343	0.000469	CcSEcCtD
Dexrazoxane—Feeling abnormal—Gemcitabine—kidney cancer	0.000343	0.000469	CcSEcCtD
Dexrazoxane—Shock—Paclitaxel—kidney cancer	0.000343	0.000469	CcSEcCtD
Dexrazoxane—Vomiting—Sorafenib—kidney cancer	0.000343	0.000469	CcSEcCtD
Dexrazoxane—Nervous system disorder—Paclitaxel—kidney cancer	0.000342	0.000468	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Paclitaxel—kidney cancer	0.000342	0.000467	CcSEcCtD
Dexrazoxane—Breast disorder—Doxorubicin—kidney cancer	0.000339	0.000464	CcSEcCtD
Dexrazoxane—Skin disorder—Paclitaxel—kidney cancer	0.000339	0.000463	CcSEcCtD
Dexrazoxane—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000338	0.000462	CcSEcCtD
Dexrazoxane—Headache—Sorafenib—kidney cancer	0.000338	0.000462	CcSEcCtD
Dexrazoxane—Diarrhoea—Dactinomycin—kidney cancer	0.000336	0.00046	CcSEcCtD
Dexrazoxane—Anorexia—Paclitaxel—kidney cancer	0.000333	0.000454	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000331	0.000453	CcSEcCtD
Dexrazoxane—Vomiting—Sunitinib—kidney cancer	0.00033	0.000451	CcSEcCtD
Dexrazoxane—Body temperature increased—Gemcitabine—kidney cancer	0.000329	0.00045	CcSEcCtD
Dexrazoxane—Tremor—Capecitabine—kidney cancer	0.000329	0.000449	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Capecitabine—kidney cancer	0.000326	0.000445	CcSEcCtD
Dexrazoxane—Headache—Sunitinib—kidney cancer	0.000325	0.000445	CcSEcCtD
Dexrazoxane—Dysphagia—Doxorubicin—kidney cancer	0.000325	0.000444	CcSEcCtD
Dexrazoxane—Anaemia—Capecitabine—kidney cancer	0.000324	0.000443	CcSEcCtD
Dexrazoxane—Nausea—Sorafenib—kidney cancer	0.000321	0.000438	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000318	0.000434	CcSEcCtD
Dexrazoxane—Malaise—Capecitabine—kidney cancer	0.000316	0.000432	CcSEcCtD
Dexrazoxane—Insomnia—Paclitaxel—kidney cancer	0.000316	0.000431	CcSEcCtD
Dexrazoxane—Asthenia—Vincristine—kidney cancer	0.000315	0.000431	CcSEcCtD
Dexrazoxane—Syncope—Capecitabine—kidney cancer	0.000315	0.00043	CcSEcCtD
Dexrazoxane—Leukopenia—Capecitabine—kidney cancer	0.000314	0.000429	CcSEcCtD
Dexrazoxane—Vomiting—Dactinomycin—kidney cancer	0.000313	0.000427	CcSEcCtD
Dexrazoxane—Dyspnoea—Paclitaxel—kidney cancer	0.000311	0.000425	CcSEcCtD
Dexrazoxane—Somnolence—Paclitaxel—kidney cancer	0.00031	0.000424	CcSEcCtD
Dexrazoxane—Nausea—Sunitinib—kidney cancer	0.000309	0.000422	CcSEcCtD
Dexrazoxane—Loss of consciousness—Capecitabine—kidney cancer	0.000308	0.000421	CcSEcCtD
Dexrazoxane—Pancytopenia—Doxorubicin—kidney cancer	0.000308	0.000421	CcSEcCtD
Dexrazoxane—Cough—Capecitabine—kidney cancer	0.000306	0.000418	CcSEcCtD
Dexrazoxane—Neutropenia—Doxorubicin—kidney cancer	0.000304	0.000415	CcSEcCtD
Dexrazoxane—Decreased appetite—Paclitaxel—kidney cancer	0.000303	0.000414	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000301	0.000412	CcSEcCtD
Dexrazoxane—Fatigue—Paclitaxel—kidney cancer	0.000301	0.000411	CcSEcCtD
Dexrazoxane—Diarrhoea—Vincristine—kidney cancer	0.000301	0.000411	CcSEcCtD
Dexrazoxane—Asthenia—Gemcitabine—kidney cancer	0.000299	0.000409	CcSEcCtD
Dexrazoxane—Myalgia—Capecitabine—kidney cancer	0.000299	0.000408	CcSEcCtD
Dexrazoxane—Pain—Paclitaxel—kidney cancer	0.000298	0.000408	CcSEcCtD
Dexrazoxane—Constipation—Paclitaxel—kidney cancer	0.000298	0.000408	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000297	0.000405	CcSEcCtD
Dexrazoxane—Discomfort—Capecitabine—kidney cancer	0.000295	0.000403	CcSEcCtD
Dexrazoxane—Pruritus—Gemcitabine—kidney cancer	0.000295	0.000403	CcSEcCtD
Dexrazoxane—Weight decreased—Doxorubicin—kidney cancer	0.000294	0.000401	CcSEcCtD
Dexrazoxane—Dry mouth—Capecitabine—kidney cancer	0.000292	0.000399	CcSEcCtD
Dexrazoxane—Nausea—Dactinomycin—kidney cancer	0.000292	0.000399	CcSEcCtD
Dexrazoxane—Pneumonia—Doxorubicin—kidney cancer	0.000291	0.000398	CcSEcCtD
Dexrazoxane—Dizziness—Vincristine—kidney cancer	0.000291	0.000397	CcSEcCtD
Dexrazoxane—Infestation NOS—Doxorubicin—kidney cancer	0.000289	0.000395	CcSEcCtD
Dexrazoxane—Infestation—Doxorubicin—kidney cancer	0.000289	0.000395	CcSEcCtD
Dexrazoxane—Feeling abnormal—Paclitaxel—kidney cancer	0.000288	0.000393	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000285	0.00039	CcSEcCtD
Dexrazoxane—Diarrhoea—Gemcitabine—kidney cancer	0.000285	0.00039	CcSEcCtD
Dexrazoxane—Infection—Capecitabine—kidney cancer	0.000284	0.000389	CcSEcCtD
Dexrazoxane—Stomatitis—Doxorubicin—kidney cancer	0.000282	0.000385	CcSEcCtD
Dexrazoxane—Shock—Capecitabine—kidney cancer	0.000282	0.000385	CcSEcCtD
Dexrazoxane—Nervous system disorder—Capecitabine—kidney cancer	0.000281	0.000384	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Capecitabine—kidney cancer	0.00028	0.000383	CcSEcCtD
Dexrazoxane—Vomiting—Vincristine—kidney cancer	0.000279	0.000382	CcSEcCtD
Dexrazoxane—Skin disorder—Capecitabine—kidney cancer	0.000278	0.00038	CcSEcCtD
Dexrazoxane—Urticaria—Paclitaxel—kidney cancer	0.000277	0.000379	CcSEcCtD
Dexrazoxane—Abdominal pain—Paclitaxel—kidney cancer	0.000276	0.000377	CcSEcCtD
Dexrazoxane—Body temperature increased—Paclitaxel—kidney cancer	0.000276	0.000377	CcSEcCtD
Dexrazoxane—Headache—Vincristine—kidney cancer	0.000275	0.000376	CcSEcCtD
Dexrazoxane—Anorexia—Capecitabine—kidney cancer	0.000273	0.000373	CcSEcCtD
Dexrazoxane—Agranulocytosis—Doxorubicin—kidney cancer	0.00027	0.000369	CcSEcCtD
Dexrazoxane—Vomiting—Gemcitabine—kidney cancer	0.000265	0.000362	CcSEcCtD
Dexrazoxane—Haemoglobin—Doxorubicin—kidney cancer	0.000261	0.000357	CcSEcCtD
Dexrazoxane—Headache—Gemcitabine—kidney cancer	0.000261	0.000357	CcSEcCtD
Dexrazoxane—Nausea—Vincristine—kidney cancer	0.000261	0.000357	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000261	0.000356	CcSEcCtD
Dexrazoxane—Haemorrhage—Doxorubicin—kidney cancer	0.00026	0.000355	CcSEcCtD
Dexrazoxane—Insomnia—Capecitabine—kidney cancer	0.000259	0.000354	CcSEcCtD
Dexrazoxane—Oedema peripheral—Doxorubicin—kidney cancer	0.000256	0.00035	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Doxorubicin—kidney cancer	0.000255	0.000349	CcSEcCtD
Dexrazoxane—Dyspnoea—Capecitabine—kidney cancer	0.000255	0.000349	CcSEcCtD
Dexrazoxane—Asthenia—Paclitaxel—kidney cancer	0.00025	0.000342	CcSEcCtD
Dexrazoxane—Decreased appetite—Capecitabine—kidney cancer	0.000249	0.00034	CcSEcCtD
Dexrazoxane—Nausea—Gemcitabine—kidney cancer	0.000248	0.000338	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000247	0.000338	CcSEcCtD
Dexrazoxane—Fatigue—Capecitabine—kidney cancer	0.000247	0.000337	CcSEcCtD
Dexrazoxane—Pruritus—Paclitaxel—kidney cancer	0.000247	0.000337	CcSEcCtD
Dexrazoxane—Pain—Capecitabine—kidney cancer	0.000245	0.000335	CcSEcCtD
Dexrazoxane—Constipation—Capecitabine—kidney cancer	0.000245	0.000335	CcSEcCtD
Dexrazoxane—Cardiac disorder—Doxorubicin—kidney cancer	0.000241	0.000329	CcSEcCtD
Dexrazoxane—Diarrhoea—Paclitaxel—kidney cancer	0.000239	0.000326	CcSEcCtD
Dexrazoxane—Feeling abnormal—Capecitabine—kidney cancer	0.000236	0.000322	CcSEcCtD
Dexrazoxane—Angiopathy—Doxorubicin—kidney cancer	0.000236	0.000322	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Capecitabine—kidney cancer	0.000234	0.00032	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Doxorubicin—kidney cancer	0.000234	0.00032	CcSEcCtD
Dexrazoxane—Dizziness—Paclitaxel—kidney cancer	0.000231	0.000315	CcSEcCtD
Dexrazoxane—Alopecia—Doxorubicin—kidney cancer	0.00023	0.000314	CcSEcCtD
Dexrazoxane—Mental disorder—Doxorubicin—kidney cancer	0.000228	0.000311	CcSEcCtD
Dexrazoxane—Urticaria—Capecitabine—kidney cancer	0.000227	0.000311	CcSEcCtD
Dexrazoxane—Body temperature increased—Capecitabine—kidney cancer	0.000226	0.000309	CcSEcCtD
Dexrazoxane—Abdominal pain—Capecitabine—kidney cancer	0.000226	0.000309	CcSEcCtD
Dexrazoxane—Erythema—Doxorubicin—kidney cancer	0.000226	0.000309	CcSEcCtD
Dexrazoxane—Malnutrition—Doxorubicin—kidney cancer	0.000226	0.000309	CcSEcCtD
Dexrazoxane—Vomiting—Paclitaxel—kidney cancer	0.000222	0.000303	CcSEcCtD
Dexrazoxane—Headache—Paclitaxel—kidney cancer	0.000219	0.000299	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Doxorubicin—kidney cancer	0.00021	0.000287	CcSEcCtD
Dexrazoxane—Anaemia—Doxorubicin—kidney cancer	0.000209	0.000286	CcSEcCtD
Dexrazoxane—Nausea—Paclitaxel—kidney cancer	0.000207	0.000283	CcSEcCtD
Dexrazoxane—Asthenia—Capecitabine—kidney cancer	0.000205	0.000281	CcSEcCtD
Dexrazoxane—Malaise—Doxorubicin—kidney cancer	0.000204	0.000279	CcSEcCtD
Dexrazoxane—Syncope—Doxorubicin—kidney cancer	0.000203	0.000277	CcSEcCtD
Dexrazoxane—Pruritus—Capecitabine—kidney cancer	0.000203	0.000277	CcSEcCtD
Dexrazoxane—Leukopenia—Doxorubicin—kidney cancer	0.000202	0.000277	CcSEcCtD
Dexrazoxane—Loss of consciousness—Doxorubicin—kidney cancer	0.000199	0.000272	CcSEcCtD
Dexrazoxane—Cough—Doxorubicin—kidney cancer	0.000197	0.00027	CcSEcCtD
Dexrazoxane—Diarrhoea—Capecitabine—kidney cancer	0.000196	0.000268	CcSEcCtD
Dexrazoxane—Myalgia—Doxorubicin—kidney cancer	0.000193	0.000263	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000191	0.000261	CcSEcCtD
Dexrazoxane—Discomfort—Doxorubicin—kidney cancer	0.00019	0.00026	CcSEcCtD
Dexrazoxane—Dizziness—Capecitabine—kidney cancer	0.000189	0.000259	CcSEcCtD
Dexrazoxane—Dry mouth—Doxorubicin—kidney cancer	0.000188	0.000257	CcSEcCtD
Dexrazoxane—Infection—Doxorubicin—kidney cancer	0.000183	0.000251	CcSEcCtD
Dexrazoxane—Vomiting—Capecitabine—kidney cancer	0.000182	0.000249	CcSEcCtD
Dexrazoxane—Shock—Doxorubicin—kidney cancer	0.000182	0.000248	CcSEcCtD
Dexrazoxane—Nervous system disorder—Doxorubicin—kidney cancer	0.000181	0.000247	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Doxorubicin—kidney cancer	0.000181	0.000247	CcSEcCtD
Dexrazoxane—Headache—Capecitabine—kidney cancer	0.000179	0.000245	CcSEcCtD
Dexrazoxane—Skin disorder—Doxorubicin—kidney cancer	0.000179	0.000245	CcSEcCtD
Dexrazoxane—Anorexia—Doxorubicin—kidney cancer	0.000176	0.00024	CcSEcCtD
Dexrazoxane—Nausea—Capecitabine—kidney cancer	0.00017	0.000232	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000168	0.00023	CcSEcCtD
Dexrazoxane—Insomnia—Doxorubicin—kidney cancer	0.000167	0.000228	CcSEcCtD
Dexrazoxane—Dyspnoea—Doxorubicin—kidney cancer	0.000165	0.000225	CcSEcCtD
Dexrazoxane—Somnolence—Doxorubicin—kidney cancer	0.000164	0.000224	CcSEcCtD
Dexrazoxane—Decreased appetite—Doxorubicin—kidney cancer	0.00016	0.000219	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000159	0.000218	CcSEcCtD
Dexrazoxane—Fatigue—Doxorubicin—kidney cancer	0.000159	0.000217	CcSEcCtD
Dexrazoxane—Pain—Doxorubicin—kidney cancer	0.000158	0.000216	CcSEcCtD
Dexrazoxane—Constipation—Doxorubicin—kidney cancer	0.000158	0.000216	CcSEcCtD
Dexrazoxane—Feeling abnormal—Doxorubicin—kidney cancer	0.000152	0.000208	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000151	0.000206	CcSEcCtD
Dexrazoxane—Urticaria—Doxorubicin—kidney cancer	0.000147	0.0002	CcSEcCtD
Dexrazoxane—Body temperature increased—Doxorubicin—kidney cancer	0.000146	0.000199	CcSEcCtD
Dexrazoxane—Abdominal pain—Doxorubicin—kidney cancer	0.000146	0.000199	CcSEcCtD
Dexrazoxane—Asthenia—Doxorubicin—kidney cancer	0.000132	0.000181	CcSEcCtD
Dexrazoxane—Pruritus—Doxorubicin—kidney cancer	0.000131	0.000178	CcSEcCtD
Dexrazoxane—Diarrhoea—Doxorubicin—kidney cancer	0.000126	0.000173	CcSEcCtD
Dexrazoxane—Dizziness—Doxorubicin—kidney cancer	0.000122	0.000167	CcSEcCtD
Dexrazoxane—Vomiting—Doxorubicin—kidney cancer	0.000117	0.00016	CcSEcCtD
Dexrazoxane—Headache—Doxorubicin—kidney cancer	0.000116	0.000158	CcSEcCtD
Dexrazoxane—Nausea—Doxorubicin—kidney cancer	0.00011	0.00015	CcSEcCtD
